High response and re‐infection rates among people who inject drugs treated for hepatitis C in a community needle and syringe programme

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

(2018) Zoe Ward et al.   ADDICTION

Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland

(2018) Hannah Fraser et al.   ADDICTION

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

(2018) Hannah Fraser et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2018

(2018) Jean-Michel Pawlotsky et al.   JOURNAL OF HEPATOLOGY

Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017

(2018) Jeffrey V Lazarus et al.   Journal of the International AIDS Society

Elbasvir–Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

(2016) Gregory J. Dore et al.   ANNALS OF INTERNAL MEDICINE

A systematic review of community based hepatitis C treatment

(2016) Amanda J. Wade et al.   BMC INFECTIOUS DISEASES

Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis

(2016) Bryony Simmons et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs

(2016) Amanda Weir et al.   DRUG AND ALCOHOL DEPENDENCE

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation

(2016) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Hepatitis C reinfection after sustained virological response

(2016) Håvard Midgard et al.   JOURNAL OF HEPATOLOGY

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

(2016) R. J. Harris et al.   JOURNAL OF VIRAL HEPATITIS

The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

(2016) Jeffrey D Stanaway et al.   LANCET

Treatment of Chronic Hepatitis C Infection among Current And Former Injection Drug Users within a Multidisciplinary Treatment Model at a Community Health Centre

(2016) Adam I Newman et al.   CANADIAN JOURNAL OF GASTROENTEROLOGY

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

(2015) Jason Grebely et al.   ADDICTION

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

(2015)   HEPATOLOGY

Directly Observed Pegylated Interferon Plus Self-Administered Ribavirin for the Treatment of Hepatitis C Virus Infection in People Actively Using Drugs: A Randomized Controlled Trial

(2013) Robert J. Hilsden et al.   CLINICAL INFECTIOUS DISEASES

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

(2013) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysis

(2013) Esther J. Aspinall et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

(2013) Natasha K. Martin et al.   HEPATOLOGY

Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C

(2013) A. Marco et al.   JOURNAL OF HEPATOLOGY

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

(2013) J. Iversen et al.   JOURNAL OF VIRAL HEPATITIS

Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

(2012) Rositsa B. Dimova et al.   CLINICAL INFECTIOUS DISEASES

Decrease in health-related quality of life associated with awareness of hepatitis C virus infection among people who inject drugs in Scotland

(2012) Scott A. McDonald et al.   JOURNAL OF HEPATOLOGY

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Health related quality of life trajectories of patients in opioid substitution treatment

(2011) Bohdan Nosyk et al.   DRUG AND ALCOHOL DEPENDENCE

Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection

(2011) Jason Grebely et al.   HEPATOLOGY

Reinfection with hepatitis C virus following sustained virological response in injection drug users

(2010) Jason Grebely et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

(2010) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin

(2010) Tarik Asselah et al.   LIVER INTERNATIONAL

Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence

(2009) Margaret Hellard et al.   CLINICAL INFECTIOUS DISEASES